Javier San Martin
CIK 1794629 · View on SEC EDGAR ↗
First SEC filing: Nov. 20, 2019 · Latest: Nov. 20, 2019
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2025 | LONA | S | 10,826 | $0.56 | $6,063 | 35,841 Direct | -23.20% | Disposed | 40.7% (price as of 2026-08-21) |
| Nov. 21, 2022 | ARWR | S 10b5-1 | 200 | $30.62 | $6,124 | 91,500 Direct | -0.22% | Disposed | 188.0% (price as of 2026-08-21) |
| Nov. 21, 2022 | ARWR | S 10b5-1 | 19,300 | $29.98 | $578,614 | 91,700 Direct | -17.39% | Disposed | 194.2% (price as of 2026-08-21) |
| Nov. 19, 2021 | ARWR | S 10b5-1 | 100 | $70.99 | $7,099 | 111,000 Direct | -0.09% | Disposed | 24.2% (price as of 2026-08-21) |
| Nov. 19, 2021 | ARWR | S 10b5-1 | 5,696 | $70.01 | $398,777 | 111,100 Direct | -4.88% | Disposed | 26.0% (price as of 2026-08-21) |
| Nov. 19, 2021 | ARWR | S 10b5-1 | 13,704 | $69.01 | $945,713 | 116,796 Direct | -10.50% | Disposed | 27.8% (price as of 2026-08-21) |
| Nov. 19, 2020 | ARWR | S 10b5-1 | 19,500 | $69.39 | $1,353,105 | 130,500 Direct | -13.00% | Disposed | 27.1% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 3, 2025 | LONA | Stock Option (Right to Buy) | Common Stock (111,270) | $0.38 | March 2, 2035 | 111,270 | Acquired |
| March 3, 2025 | LONA | Restricted Stock Units | Common Stock (74,180) | — | — | 74,180 | Acquired |
| Dec. 31, 2024 | LONA | Restricted Stock Units [F3] | Common Stock (46,667) | — | — | 46,667 | Disposed |
| Oct. 1, 2024 | LONA | Restricted Stock Units | Common Stock (140,000) | — | — | 140,000 | Acquired |
| Oct. 1, 2024 | LONA | Stock Option (Right to Buy) | Common Stock (140,000) | $0.45 | Sept. 30, 2034 | 140,000 | Acquired |
| April 15, 2024 | LONA | Stock Option (Right to Buy) | Common Stock (400,000) | $2.06 | April 14, 2034 | 400,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Nov. 20, 2019 | ARWR | Common Stock | — | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
LONA
M.D., Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $500,000 | $100,000 | $27,907 | $182,143 | — | — | $85 | $810,134 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.